Woburn, MA – According to filings with the U.S. Securities and Exchange Commission, Spear Bio is raising $3,000,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Michael Natan played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Spear Bio
Wellness self-testing and telemedicine-based diagnostics are quickly growing trends. Both increasingly rely on the ability to quantify miniscule amounts of protein biomarkers from at-home collected samples. Platform technologies that enable ultrasensitive detection from small sample volumes and fit into existing workflows for sample collection, processing, and detection, are needed to enable these highly-valued trends. Spear Bio Inc. has developed a reagent-based technology for ultrasensitive protein detection. This novel solution offers significant benefits across the healthcare value chain.

To learn more about Spear Bio, visit http://www.spear.bio/

Contact:
Michael Natan, President and Chief Executive Officer
978-406-1169
https://www.linkedin.com/in/michael-natan-5b73113/

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved